A law firm investigating a possible legal case against Hargreaves Lansdown in the wake of the closure of Neil Woodford’s flagship fund has received inquiries from more than 500 investors with millions of pounds locked up.
The markets were mixed as traders remained on tenterhooks ahead of the pivotal update from the Federal Reserve.
Harrods has announced plans to a new beauty store which will be its first standalone store outside of London.
Drugmaker GlaxoSmithKline (GSK) has upgraded its earnings forecast as its shingles vaccine performed much better than expected, for the second time in a year.
Standard Chartered has shrugged off protests in Hong Kong and a slowdown in the global economy to post a hike in third-quarter profits.
The number of people going financially insolvent across England and Wales has remained at near-decade highs after a surge in individual voluntary arrangements, official figures show.
Energy customers who reject new smart meters have been warned that the cost to them of maintaining “relic meters” will be “very high”.
Sports Direct founder Mike Ashley has attacked the competition watchdog over its investigation into the takeover of Footasylum by JD Sports.
AstraZeneca has signed a 239 million US dollar (£186 million) deal to sell a revenue-generating anti-psychotic drug as it bids to move away from mature treatments and invest in innovation.
Passport and banknote maker De La Rue continued its freefall on Wednesday as bosses issued a second profit warning in five months.